Literature DB >> 19894026

Neurotrophic actions of bone marrow stromal cells on primary culture of dorsal root ganglion tissues and neurons.

Yun Gu1, Jie Wang, Fei Ding, Nan Hu, Yaxian Wang, Xiaosong Gu.   

Abstract

Application of adult bone marrow stromal cells (BMSCs) provides therapeutic benefits to the treatment of neurological insults. The aim of this study was to explore the potential of nonhematopoietic BMSCs to produce soluble factors and stimulate signaling pathways in neurons that mediate trophic effects. A combination of enzyme-linked immunosorbent assay and two-dimensional gel electrophoresis coupled with mass spectrometry showed that the BMSCs released into the culture medium an array of soluble factors such as nerve growth factor, brain-derived neurotrophic factor, basic fibroblast growth factor, and ciliary neurotrophic factor, which have been shown to exhibit potent neurotrophic effects on neural cells. Immunochemistry, cell viability assay, and quantitative real-time RT-PCR collectively showed that neurite outgrowth and neurogenesis in cultured rat dorsal root ganglion (DRG) explants and neurons were enhanced after they were cocultured with rat BMSCs. Western blot analysis revealed that BMSC-conditioned medium activated phosphorylation of mitogen-activated protein kinase/extracellular signal-regulated protein kinase and/or phosphoinositide 3-kinase/serine/threonine kinase (PI3K/Akt) in primary culture of rat DRG neurons, which suggested that BMSCs trigger endogenous survival signaling pathways in neurons through their secreted soluble factors. Our data help to elucidate the mechanisms by which BMSCs function as a cell therapy agent in peripheral nerve regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894026     DOI: 10.1007/s12031-009-9304-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  46 in total

1.  Neurospheres induced from bone marrow stromal cells are multipotent for differentiation into neuron, astrocyte, and oligodendrocyte phenotypes.

Authors:  Hidenori Suzuki; Toshihiko Taguchi; Hiroshi Tanaka; Hideo Kataoka; Zhenglin Li; Keiichi Muramatsu; Toshikazu Gondo; Shinya Kawai
Journal:  Biochem Biophys Res Commun       Date:  2004-09-24       Impact factor: 3.575

Review 2.  Coaxing bone marrow stromal mesenchymal stem cells towards neuronal differentiation: progress and uncertainties.

Authors:  Y Chen; F Y H Teng; B L Tang
Journal:  Cell Mol Life Sci       Date:  2006-07       Impact factor: 9.261

3.  Investigation of differentially expressed proteins in rat gastrocnemius muscle during denervation-reinnervation.

Authors:  Hualin Sun; Jie Liu; Fei Ding; Xiaodong Wang; Mei Liu; Xiaosong Gu
Journal:  J Muscle Res Cell Motil       Date:  2006-06-04       Impact factor: 2.698

4.  Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells.

Authors:  A Mahmood; D Lu; L Wang; Y Li; M Lu; M Chopp
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

5.  Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats.

Authors:  Asim Mahmood; Dunyue Lu; Changsheng Qu; Anton Goussev; Michael Chopp
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

6.  Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury.

Authors:  D Lu; Y Li; L Wang; J Chen; A Mahmood; M Chopp
Journal:  J Neurotrauma       Date:  2001-08       Impact factor: 5.269

7.  Neuroprotective effects of bone marrow stromal cells on rat organotypic hippocampal slice culture model of cerebral ischemia.

Authors:  Chi Zhong; Zhen Qin; Chun-Jiu Zhong; Yang Wang; Xin-Ya Shen
Journal:  Neurosci Lett       Date:  2003-05-15       Impact factor: 3.046

8.  Regeneration of sciatic nerves of adult rats induced by extracts from distal stumps of pre-degenerated peripheral nerves.

Authors:  Wieslaw Marcol; Katarzyna Kotulska; Ewa Swiech-Sabuda; Magdalena Larysz-Brysz; Beata Gołka; Dariusz Górka; Joanna Lewin-Kowalik
Journal:  J Neurosci Res       Date:  2003-05-01       Impact factor: 4.164

9.  Ischemic rat brain extracts induce human marrow stromal cell growth factor production.

Authors:  Xiaoguang Chen; Yi Li; Lei Wang; Mark Katakowski; Lijie Zhang; Jieli Chen; Yongxian Xu; Subhash C Gautam; Michael Chopp
Journal:  Neuropathology       Date:  2002-12       Impact factor: 1.906

10.  Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination.

Authors:  S Einheber; T A Milner; F Giancotti; J L Salzer
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

View more
  24 in total

1.  Osteoblasts are inherently programmed to repel sensory innervation.

Authors:  Luís Leitão; Estrela Neto; Francisco Conceição; Ana Monteiro; Marina Couto; Cecília J Alves; Daniela M Sousa; Meriem Lamghari
Journal:  Bone Res       Date:  2020-05-13       Impact factor: 13.567

2.  Bone marrow stromal cells promote neurite outgrowth of spinal motor neurons by means of neurotrophic factors in vitro.

Authors:  Weiwei Lin; Ming Li; Yi Li; Xiaoli Sun; Xiang Li; Fan Yang; Yuejiao Huang; Xiaodong Wang
Journal:  Neurol Sci       Date:  2013-07-06       Impact factor: 3.307

3.  Basic fibroblast growth factor (bFGF) facilitates differentiation of adult dorsal root ganglia-derived neural stem cells toward Schwann cells by binding to FGFR-1 through MAPK/ERK activation.

Authors:  Yun Gu; Chenbin Xue; Jianbin Zhu; Hualin Sun; Fei Ding; Zheng Cao; Xiaosong Gu
Journal:  J Mol Neurosci       Date:  2013-09-27       Impact factor: 3.444

4.  MALDI mass spectrometry imaging of neuronal cell cultures.

Authors:  Tyler A Zimmerman; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-26       Impact factor: 3.109

5.  Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium-Safety and Efficacy of Clinical Use for Neurotransplantation.

Authors:  Hideo Shichinohe; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Masahito Kawabori; Mitsufumi Nishio; Yukari Takeda; Takao Koike; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-06-11       Impact factor: 6.829

Review 6.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

7.  3D-printed nerve guidance conduits multi-functionalized with canine multipotent mesenchymal stromal cells promote neuroregeneration after sciatic nerve injury in rats.

Authors:  Diego Noé Rodríguez-Sánchez; Giovana Boff Araujo Pinto; Luciana Politti Cartarozzi; Alexandre Leite Rodrigues de Oliveira; Ana Livia Carvalho Bovolato; Marcio de Carvalho; Jorge Vicente Lopes da Silva; Janaina de Andréa Dernowsek; Marjorie Golim; Benedito Barraviera; Rui Seabra Ferreira; Elenice Deffune; Mathues Bertanha; Rogério Martins Amorim
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

8.  Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential.

Authors:  Tom J Burdon; Arghya Paul; Nicolas Noiseux; Satya Prakash; Dominique Shum-Tim
Journal:  Bone Marrow Res       Date:  2010-12-06

9.  Let-7 microRNAs regenerate peripheral nerve regeneration by targeting nerve growth factor.

Authors:  Shiying Li; Xinghui Wang; Yun Gu; Chu Chen; Yaxian Wang; Jie Liu; Wen Hu; Bin Yu; Yongjun Wang; Fei Ding; Yan Liu; Xiaosong Gu
Journal:  Mol Ther       Date:  2014-11-14       Impact factor: 11.454

10.  Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats.

Authors:  Norihiko Nakano; Yoshiyasu Nakai; Tae-Beom Seo; Tamami Homma; Yoshihiro Yamada; Masayoshi Ohta; Yoshihisa Suzuki; Toshio Nakatani; Masanori Fukushima; Miki Hayashibe; Chizuka Ide
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.